Saturday 17 October 2026
Export STIM’s income statement to Excel — free account
Neuronetics, Inc.
STIM Healthcare Medical Devices
Neuronetics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $149.2 million, up 99.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.08%, EPS grew 66.7%, free cash flow grew 62.1% and total debt rose 10.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
1.89
0.06
−3.08%
Follow STIM
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
3 | 4 | 3 | 4 |
| (218.46%) | (134.39%) | (131.16%) | (114.52%) | ||
| (40.53%) | (27.61%) | (27.76%) | (22.87%) | ||
ROIC |
(37.93%) | (34.06%) | (31.09%) | (24.64%) | |
Return on Tangible Assets |
(108.85%) | (109.87%) | (163.03%) | (107.21%) | |
Average Days of Receivables |
53.92 | 41.34 | 39.02 | 38.29 | |
Free Cash Flow per Share |
(0.45) | (0.32) | (0.19) | (0.15) | |
Free Cash Flow |
(30.55) | (21.17) | (13.56) | (11.22) | |
Capital Expenditures |
(0.67) | (0.80) | (0.75) | (0.92) | |
| Other line items | |||||
Cash ROIC |
(23.20%) | (16.75%) | (13.89%) | (10.36%) | |
Accounts Receivable Turnover |
6.75 | 7.24 | 7.04 | 7.23 | |
Accounts Payable Turnover |
8.66 | 7.05 | 7.92 | 7.13 | |
Inventory Turnover |
13.87 | 17.92 | 17.97 | 15.11 | |
Average Days of Payables |
65.62 | 51.01 | 52.88 | 57.45 | |
Days of Inventory on Hand |
24.50 | 20.55 | 21.81 | 25.45 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
8.23% | 4.41% | 4.18% | 3.78% | |
Selling, General and Administrative Expense of Revenue |
71.35% | 65.14% | 63.18% | 60.08% | |
Share Based Compensation of Revenue |
4.58% | 4.59% | 4.67% | 3.84% | |
Interest Coverage |
(4.82) | (3.74) | (3.36) | (2.56) | |
Operating CF/Net income |
0.67 | 0.52 | 0.34 | 0.34 | |
Depreciation/Fixed assets |
0.64 | 0.78 | 0.85 | 0.90 | |
Capex/Depreciation |
(0.21) | (0.23) | (0.23) | (0.29) | |
Revenue per Share |
1.93 | 2.26 | 2.18 | 2.12 | |
Operating CF per Share |
(0.44) | (0.31) | (0.18) | (0.14) | |
Capex per Share |
(0.01) | (0.01) | (0.01) | (0.01) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates